Listed

NEUROONE MEDICAL TECHNOLOGIES Corp: Form 10-K for the period ended Dec 31, 2015

Filed with the SEC on Apr 14, 2016 and accepted by EDGAR at Apr 14, 2016, 20:19 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2015-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2015-01-01 to 2015-12-31$742us-gaap:SalesRevenueNet
Operating income12 months2015-01-01 to 2015-12-31−$48.8kus-gaap:OperatingIncomeLoss
Interest expense12 months2015-01-01 to 2015-12-31$14.0kus-gaap:InterestExpense
Income tax12 months2015-01-01 to 2015-12-31$0us-gaap:IncomeTaxExpenseBenefit
Net income12 months2015-01-01 to 2015-12-31−$62.9kus-gaap:NetIncomeLoss
Diluted EPS12 months2015-01-01 to 2015-12-31−$0.01us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow12 months2015-01-01 to 2015-12-31−$45.2kus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Cash and equivalentsAt period end2015-12-31$1.8kus-gaap:Cash
Current assetsAt period end2015-12-31$1.8kus-gaap:AssetsCurrent
Total assetsAt period end2015-12-31$1.8kus-gaap:Assets
Current liabilitiesAt period end2015-12-31$83.3kus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2015-12-31$83.3kus-gaap:Liabilities
Shareholders' equityAt period end2015-12-31−$81.5kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001144204-16-094382. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.